-Phase III trial enrolled a total of 480 patients with moderate to severe acne-Topline results expected in the second quarter 2025 This Phase III clinical trial is a randomized, double-blind, ...

Acne is one of the predominant chronic skin diseases in the world. Up to 9.4% of the global population have developed it at some point in their lives. This condition can take on many forms, from mild ...

No matter your age, having persistent acne can feel disheartening. You may have tried countless treatment options, ranging from dietary changes to medical treatment, but nothing has worked. Some ...

Home remedies, such as cleansing the skin, applying ice, and using benzoyl peroxide, can help shrink a cystic pimple. However, in some cases, cystic acne may require dermatological help. Cystic acne ...

Some emerging evidence suggests that vitamin D can help with the symptoms of acne for those who have a vitamin D deficiency. Exposure to sunlight is a significant source of vitamin D. People might ...

HANGZHOU, China, Nov. 12, 2024 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces completion of enrollment of 480 patients for Phase III clinical trial of ASC40 (denifanstat ...